Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$45.37 +0.85 (+1.91%)
As of: Nov 12, 2026 · 2:11 PM EST

Rigel Pharmaceuticals (RIGL) Sales of Property, Plant and Equipment (2017 - 2024)

Updated

Rigel Pharmaceuticals (RIGL) posted Sales of Property, Plant and Equipment of $72,000 for Q4 2024, down 34.5% from $110,000 a year earlier.

Analysis

Rigel Pharmaceuticals (RIGL) Sales of Property, Plant and Equipment (2017 - 2024) Analysis & Trends

For FY2024, Rigel Pharmaceuticals' Sales of Property, Plant and Equipment came in at $98,000, down 62.2% from FY2023.

  • In prior years, Rigel Pharmaceuticals' Sales of Property, Plant and Equipment was $259,000 in FY2023 (-71.0%) and $893,000 in FY2022.
  • The Q4 2024 figure stands as the lowest quarterly Sales of Property, Plant and Equipment since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -4.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Rigel Pharmaceuticals 826.82 Mn 330.55 Mn 70.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 72,000.00
Dec 31, 2023 110,000.00
Sep 30, 2023 22,000.00
Mar 31, 2023 127,000.00
Dec 31, 2022 350,000.00
Sep 30, 2022 279,000.00
Mar 31, 2017 732,000.00
API Access

Rigel Pharmaceuticals Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=RIGL&period=max&api_key=YOUR_API_KEY